Extended Data Fig. 4: Morphologic evidence of myeloid differentiation.
From: The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia
Photomicrographs of bone marrow biopsies demonstrating morphologic evidence of myeloid differentiation in a patient who achieved complete remission; magnification is 40x.
